Medical News

RSS

Mental health laws delayed to take into account public opinion

The Victorian government has extended the closing date for public comment on changes to the state’s Mental Health Act. The deadline has been extended to February 28. Submissions on the Exposure Draft Mental Health Bill 2010 can be lodged online.

26 Jan 2011

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

RNL BIO CO., LTD, a leading biopharmaceutical company specialized in adult stem cell therapeutics, announced on January 21, 2011 another successful patient report utilizing stem cell therapy on a leading US orthopedic spine surgeon who suffered from Autoimmune Arthritis.

26 Jan 2011

Pill for multiple sclerosis in the pipeline

Multiple Sclerosis or MS is a severely disabling disease that affects 100,000 in the UK. Now a new pill has been developed to treat multiple sclerosis which means there would be no need for injections. European health experts - European Medicines Agency (EMA) have given the new drug Gilenya, the brand name for the drug fingolimod, approval which would grant it EU wide acceptance.

25 Jan 2011

Survival following transplant surgery for liver cancer not impacted by HIV-positive status

French researchers determined that infection with human immunodeficiency virus (HIV) impaired results of transplant surgery for liver cancer, with more HIV infected patients dropping off the transplantation wait list. The team found that overall survival and recurrence-free survival was not impacted following liver transplantation in patients with controlled HIV disease.

25 Jan 2011

Evaluating patients for genetic variations impacts adherence to antiviral therapy

In two recent studies, researchers have identified two functional variants in the inosine triphosphatase (ITPA) gene that protect patients with hepatitis C virus (HCV) against anemia brought on by antiviral treatment. The ability to identify those patients protected against treatment-induced anemia will ensure completion of antiviral therapy and successful elimination of the virus.

25 Jan 2011

Quest Diagnostics fourth quarter revenues decrease 1.3% to $1.8 billion

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced that for the fourth quarter ended December 31, 2010, income from continuing operations was $167 million, or $0.97 per diluted share, compared to $182 million, or $0.97 per diluted share, for the fourth quarter of 2009.

From Quest Diagnostics 25 Jan 2011

Nordion and Sterigenics sign five year contract for Cobalt-60 supply

Nordion Inc., a leading provider of products and services to the global health science market, today announced it has signed a five-year contract with Sterigenics International, a global leader in contract sterilization and ionization services, for the supply of Cobalt-60. Under the terms of the agreement, this contract extends until October 31, 2015.

25 Jan 2011

Mylan enters settlement agreement with Pfizer for Caduet Tablets litigation

Mylan Inc. today announced that it has entered into a settlement agreement with Pfizer Inc. resolving litigation related to Caduet® Tablets, 2.5 mg/10, 2.5 mg/20 mg, 2.5 mg/40 mg, 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 5 mg/80 mg, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg, known generically as Amlodipine Besylate/Atorvastatin Calcium Tablets.

25 Jan 2011

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

Johnson & Johnson today announced sales of $15.6 billion for the fourth quarter of 2010, a decrease of 5.5% as compared to the fourth quarter of 2009. Operational sales declined 5.1% and the negative impact of currency was 0.4%. Domestic sales declined 8.1%, while international sales declined 3.1%, reflecting an operational decline of 2.3% and a negative currency impact of 0.8%.

25 Jan 2011

FDA grants BioSante Orphan Drug designation for Melanoma Cancer Vaccine

BioSante Pharmaceuticals, Inc. today announced the receipt of Orphan Drug designation for its Melanoma Cancer Vaccine in the treatment of stage IIb to IV melanoma, from the FDA's Office of Orphan Products Development. Melanoma is the most deadly form of skin cancer.

25 Jan 2011

First Edition: January 25, 2011

Today's health policy headlines include speculation about what President Barack Obama will say during tonight's State of The Union address and how the GOP will respond to it.

25 Jan 2011

NanoString Technologies launches nCounter Mouse miRNA Expression Assay Kit

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the expansion of its microRNA (miRNA) product line with a multiplexed assay for profiling the mouse miRNA transcriptome.

From NanoString Technologies 25 Jan 2011

Corning fourth quarter sales increase 15% to $1.77 billion

Corning Incorporated today announced its results for the fourth quarter of 2010.

25 Jan 2011

Emergent BioSolutions initiates TRU-016 Phase Ib/II study for chronic lymphocytic leukemia

Emergent BioSolutions Inc. today announced the initiation of a Phase Ib/II study (16201) of TRU-016 for chronic lymphocytic leukemia (CLL). TRU-016 is a CD37-directed Small Modular ImmunoPharmaceutical (SMIP™) protein therapeutic in development for the treatment of B-cell malignancies. TRU-016 is being developed in collaboration with Abbott.

25 Jan 2011

Waters fourth quarter sales increase 13% to $484 million

Waters Corporation reported fourth quarter 2010 sales of $484 million, an increase of 13% from sales of $429 million in the fourth quarter of 2009. In the quarter, foreign currency translation was about neutral to sales growth. On a GAAP basis, earnings per diluted share (E.P.S.) for the fourth quarter were $1.36 compared to $1.08 for the fourth quarter of 2009.

25 Jan 2011

Arizona State University sponsored forum addresses child health crises in America

Richard Carmona, MD, MPH, FACS, 17th Surgeon General of the U.S. (2002-2006), said there is "no choice but to act" today to find solutions to the child obesity epidemic and mental health problems in the nation at a forum attended by more than 200 health leaders at the National Press Club. Dr. Carmona made his remarks at "America's Children at Peril: Solving the Child Obesity and Mental Health Epidemics," a forum sponsored by Arizona State University and its College of Nursing & Health Innovation.

25 Jan 2011

Majority of the public favor physician-assisted suicide for terminally ill patients in great pain

A new Harris/BBC World News America poll finds that large majorities of Americans now favor physician assisted suicide and euthanasia for terminally ill patients in great pain who wish to end their lives. It also finds that a majority of people over 65 now have written directives regarding the type of care they would like to receive, or not to receive, at the end stages of their lives.

25 Jan 2011

Realignment with participants' interest important for future of genomic research

Obtaining consent for genetic studies can be an opportunity for researchers to foster respectful engagement with participants, not merely to mitigate legal risk. This shift is proposed in a policy forum appearing tomorrow, Jan. 21, in Science, the journal of the American Academy for the Advancement of Science.

25 Jan 2011

Massive drinks mean massive calories

When you're ordering the new Starbucks "trenta" you're not only getting a massive drink (31 ounces) but massive calories (up to 600) - with the potential to pack on more than 60 extra pounds in one year.

25 Jan 2011

IRIS International places 40 iQ200 Elite Automated Urine Microscopy Analyzers in Mexico in 2010

IRIS International, Inc., a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high value personalized diagnostics testing services through its CLIA certified molecular diagnostics laboratory,has begun to significantly penetrate the Mexican healthcare market with the initial placement in 2010 of 40 iQ®200 Elite™ Automated Urine Microscopy Analyzers within one of the largest social security healthcare systems in Mexico.

25 Jan 2011

Medical News

Mental health laws delayed to take into account public opinion

Spine surgeon successfully treated with RNL Bio's stem cell therapy for Autoimmune Arthritis

Pill for multiple sclerosis in the pipeline

Survival following transplant surgery for liver cancer not impacted by HIV-positive status

Evaluating patients for genetic variations impacts adherence to antiviral therapy

Quest Diagnostics fourth quarter revenues decrease 1.3% to $1.8 billion

Nordion and Sterigenics sign five year contract for Cobalt-60 supply

Mylan enters settlement agreement with Pfizer for Caduet Tablets litigation

Johnson & Johnson fourth quarter sales decreases 5.5% to $15.6 billion

FDA grants BioSante Orphan Drug designation for Melanoma Cancer Vaccine

First Edition: January 25, 2011

NanoString Technologies launches nCounter Mouse miRNA Expression Assay Kit

Corning fourth quarter sales increase 15% to $1.77 billion

Emergent BioSolutions initiates TRU-016 Phase Ib/II study for chronic lymphocytic leukemia

Waters fourth quarter sales increase 13% to $484 million

Arizona State University sponsored forum addresses child health crises in America

Majority of the public favor physician-assisted suicide for terminally ill patients in great pain

Realignment with participants' interest important for future of genomic research

Massive drinks mean massive calories

IRIS International places 40 iQ200 Elite Automated Urine Microscopy Analyzers in Mexico in 2010

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News